OptiBiotix Health Plc (AIM: OPTI)
London
· Delayed Price · Currency is GBP · Price in GBX19.50
-1.50 (-7.14%)
Dec 18, 2024, 3:28 PM GMT+1
OptiBiotix Health Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.57 | 0.64 | 0.46 | 2.21 | 1.52 | 0.69 | Upgrade
|
| Revenue Growth (YoY) | -17.42% | 40.92% | -79.35% | 45.28% | 121.54% | 33.70% | Upgrade
|
| Cost of Revenue | 0.3 | 0.32 | 0.21 | 1.09 | 0.64 | 0.32 | Upgrade
|
| Gross Profit | 0.27 | 0.32 | 0.24 | 1.12 | 0.88 | 0.36 | Upgrade
|
| Selling, General & Admin | 2.06 | 1.81 | 2.51 | 2.2 | 1.74 | 1.99 | Upgrade
|
| Operating Expenses | 2.27 | 2.02 | 2.73 | 2.49 | 1.99 | 2.19 | Upgrade
|
| Operating Income | -2 | -1.7 | -2.49 | -1.37 | -1.11 | -1.83 | Upgrade
|
| Interest Expense | - | - | - | -0.05 | -0.04 | -0.04 | Upgrade
|
| Interest & Investment Income | 0 | 0 | - | - | 0 | 0 | Upgrade
|
| Earnings From Equity Investments | -0.22 | -0.32 | -0.08 | - | -0.3 | -0.5 | Upgrade
|
| EBT Excluding Unusual Items | -2.22 | -2.02 | -2.57 | -1.41 | -1.46 | -2.37 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.77 | -0.03 | -16.63 | 7.59 | 7.17 | 0.25 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 21.65 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.17 | Upgrade
|
| Pretax Income | -2.99 | -2.04 | 2.44 | 6.18 | 5.71 | -2.3 | Upgrade
|
| Income Tax Expense | -0 | -0 | -0.15 | -0.08 | -0.09 | -0.11 | Upgrade
|
| Earnings From Continuing Operations | -2.98 | -2.04 | 2.59 | 6.26 | 5.8 | -2.19 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 0 | Upgrade
|
| Net Income | -2.98 | -2.04 | 2.59 | 6.26 | 5.8 | -2.19 | Upgrade
|
| Net Income to Common | -2.98 | -2.04 | 2.59 | 6.26 | 5.8 | -2.19 | Upgrade
|
| Net Income Growth | - | - | -58.68% | 7.91% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 93 | 90 | 88 | 88 | 87 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 93 | 90 | 93 | 96 | 96 | 85 | Upgrade
|
| Shares Change (YoY) | 5.52% | -3.24% | -2.43% | -0.04% | 12.09% | 3.68% | Upgrade
|
| EPS (Basic) | -0.03 | -0.02 | 0.03 | 0.07 | 0.07 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.02 | 0.03 | 0.07 | 0.06 | -0.03 | Upgrade
|
| EPS Growth | - | - | -57.56% | 7.91% | - | - | Upgrade
|
| Free Cash Flow | -1.69 | -1.53 | -1.11 | -1.57 | -0.93 | - | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | - | Upgrade
|
| Gross Margin | 47.98% | 49.69% | 53.39% | 50.75% | 57.76% | 52.73% | Upgrade
|
| Operating Margin | -351.67% | -263.20% | -544.64% | -61.68% | -72.96% | -265.97% | Upgrade
|
| Profit Margin | -524.43% | -316.61% | 566.08% | 282.92% | 380.89% | -317.80% | Upgrade
|
| Free Cash Flow Margin | -296.31% | -237.11% | -242.67% | -70.72% | -60.92% | - | Upgrade
|
| EBITDA | -1.78 | -1.49 | -2.27 | -1.08 | -0.86 | - | Upgrade
|
| EBITDA Margin | - | -231.37% | - | -48.67% | -56.69% | - | Upgrade
|
| D&A For EBITDA | 0.22 | 0.21 | 0.22 | 0.29 | 0.25 | - | Upgrade
|
| EBIT | -2 | -1.7 | -2.49 | -1.37 | -1.11 | -1.83 | Upgrade
|
| EBIT Margin | - | -263.20% | - | -61.68% | -72.96% | -265.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.